Witold K. Surewicz - Publications

Affiliations: 
Case Western Reserve University School of Medicine, Cleveland, OH, United States 
Area:
General Biophysics, Biochemistry

137 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Li Q, Jaroniec CP, Surewicz WK. Cryo-EM structure of disease-related prion fibrils provides insights into seeding barriers. Nature Structural & Molecular Biology. PMID 36097290 DOI: 10.1038/s41594-022-00833-4  0.366
2022 Qi Z, Surewicz K, Surewicz WK, Jaroniec CP. Influence of the Dynamically Disordered N-Terminal Tail Domain on the Amyloid Core Structure of Human Y145Stop Prion Protein Fibrils. Frontiers in Molecular Biosciences. 9: 841790. PMID 35237664 DOI: 10.3389/fmolb.2022.841790  0.324
2021 Li Q, Babinchak WM, Surewicz WK. Cryo-EM structure of amyloid fibrils formed by the entire low complexity domain of TDP-43. Nature Communications. 12: 1620. PMID 33712624 DOI: 10.1038/s41467-021-21912-y  0.344
2020 Dao HH, Hlaing MZ, Ma Y, Surewicz K, Surewicz WK, Jaroniec CP. C and N chemical shift assignments of A117V and M129V human Y145Stop prion protein amyloid fibrils. Biomolecular Nmr Assignments. PMID 33123960 DOI: 10.1007/s12104-020-09981-4  0.395
2020 Nemani SK, Xiao X, Cali I, Cracco L, Puoti G, Nigro M, Lavrich J, Bharara Singh A, Appleby BS, Sim VL, Notari S, Surewicz WK, Gambetti P. A novel mechanism of phenotypic heterogeneity in Creutzfeldt-Jakob disease. Acta Neuropathologica Communications. 8: 85. PMID 32560672 DOI: 10.1186/S40478-020-00966-X  0.384
2020 Singh V, Xu L, Boyko S, Surewicz K, Surewicz WK. Zinc promotes liquid-liquid phase separation of tau protein. The Journal of Biological Chemistry. PMID 32229582 DOI: 10.1074/Jbc.Ac120.013166  0.323
2020 Babinchak WM, Surewicz WK. Liquid-Liquid Phase Separation and Its Mechanistic Role in Pathological Protein Aggregation. Journal of Molecular Biology. 432: 1910-1925. PMID 32169484 DOI: 10.1016/J.Jmb.2020.03.004  0.427
2019 Cracco L, Xiao X, Nemani SK, Lavrich J, Cali I, Ghetti B, Notari S, Surewicz WK, Gambetti P. Gerstmann-Sträussler-Scheinker disease revisited: accumulation of covalently-linked multimers of internal prion protein fragments. Acta Neuropathologica Communications. 7: 1. PMID 31142381 DOI: 10.1186/S40478-019-0734-2  0.395
2019 Boyko S, Qi X, Chen TH, Surewicz K, Surewicz WK. Liquid-liquid phase separation of tau protein: The crucial role of electrostatic interactions. The Journal of Biological Chemistry. PMID 31097543 DOI: 10.1074/Jbc.Ac119.009198  0.33
2019 Babinchak WM, Haider R, Dumm BK, Sarkar P, Surewicz K, Choi JK, Surewicz WK. The role of liquid-liquid phase separation in aggregation of the TDP-43 low complexity domain. The Journal of Biological Chemistry. PMID 30814253 DOI: 10.1074/Jbc.Ra118.007222  0.346
2019 Baskakov IV, Caughey B, Requena JR, Sevillano AM, Surewicz WK, Wille H. The Prion 2018 round tables (I): The structure of PrP. Prion. PMID 30646817 DOI: 10.1080/19336896.2019.1569450  0.375
2018 Peng Y, Cao S, Kiselar J, Xiao X, Du Z, Hsieh A, Ko S, Chen Y, Agrawal P, Zheng W, Shi W, Jiang W, Yang L, Chance MR, Surewicz WK, et al. A Metastable Contact and Structural Disorder in the Estrogen Receptor Transactivation Domain. Structure (London, England : 1993). PMID 30581045 DOI: 10.1016/J.Str.2018.10.026  0.351
2018 Theint T, Xia Y, Nadaud PS, Mukhopadhyay D, Schwieters CD, Surewicz K, Surewicz WK, Jaroniec CP. Structural Studies of Amyloid Fibrils by Paramagnetic Solid-State Nuclear Magnetic Resonance Spectroscopy. Journal of the American Chemical Society. PMID 30295029 DOI: 10.1021/Jacs.8B06758  0.436
2018 Shannon M, Theint T, Mukhopadhyay D, Surewicz K, Surewicz W, Marion D, Schanda P, Jaroniec CP. Conformational Dynamics in the Core of Human Y145Stop Prion Protein Amyloid Probed by Relaxation Dispersion NMR. Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry. PMID 30276945 DOI: 10.1002/Cphc.201800779  0.406
2018 Li Q, Wang F, Xiao X, Kim C, Bohon J, Kiselar J, Safar JG, Ma J, Surewicz WK. Structural attributes of mammalian prion infectivity: Insights from studies with synthetic prions. The Journal of Biological Chemistry. PMID 30275016 DOI: 10.1074/Jbc.Ra118.005622  0.462
2018 Kim C, Xiao X, Chen S, Haldiman T, Smirnovas V, Kofskey D, Warren M, Surewicz K, Maurer NR, Kong Q, Surewicz W, Safar JG. Artificial strain of human prions created in vitro. Nature Communications. 9: 2166. PMID 29867164 DOI: 10.1038/S41467-018-04584-Z  0.405
2018 Aucoin D, Xia Y, Theint T, Nadaud PS, Surewicz K, Surewicz WK, Jaroniec CP. Protein-solvent interfaces in human Y145Stop prion protein amyloid fibrils probed by paramagnetic solid-state NMR spectroscopy. Journal of Structural Biology. PMID 29679649 DOI: 10.1016/J.Jsb.2018.04.002  0.476
2018 Nieznanska H, Bandyszewska M, Surewicz K, Zajkowski T, Surewicz WK, Nieznanski K. Identification of prion protein-derived peptides of potential use in Alzheimer's disease therapy. Biochimica Et Biophysica Acta. 1864: 2143-2153. PMID 29604335 DOI: 10.1016/J.Bbadis.2018.03.023  0.412
2017 Abskharon R, Dang J, Elfarash A, Wang Z, Shen P, Zou LS, Hassan S, Wang F, Fujioka H, Steyaert J, Mulaj M, Surewicz WK, Castilla J, Wohlkonig A, Zou WQ. Soluble polymorphic bank vole prion proteins induced by co-expression of quiescin sulfhydryl oxidase in E. coli and their aggregation behaviors. Microbial Cell Factories. 16: 170. PMID 28978309 DOI: 10.1186/S12934-017-0782-X  0.446
2017 Theint T, Nadaud PS, Aucoin D, Helmus JJ, Pondaven SP, Surewicz K, Surewicz WK, Jaroniec CP. Species-dependent structural polymorphism of Y145Stop prion protein amyloid revealed by solid-state NMR spectroscopy. Nature Communications. 8: 753. PMID 28963458 DOI: 10.1038/S41467-017-00794-Z  0.484
2017 Wang F, Wang X, Orrú CD, Groveman BR, Surewicz K, Abskharon R, Imamura M, Yokoyama T, Kim YS, Vander Stel KJ, Sinniah K, Priola SA, Surewicz WK, Caughey B, Ma J. Self-propagating, protease-resistant, recombinant prion protein conformers with or without in vivo pathogenicity. Plos Pathogens. 13: e1006491. PMID 28704563 DOI: 10.1371/Journal.Ppat.1006491  0.42
2017 Bett C, Lawrence J, Kurt TD, Orru C, Aguilar-Calvo P, Kincaid AE, Surewicz WK, Caughey B, Wu C, Sigurdson CJ. Enhanced neuroinvasion by smaller, soluble prions. Acta Neuropathologica Communications. 5: 32. PMID 28431576 DOI: 10.1186/S40478-017-0430-Z  0.341
2017 Aguilar-Calvo P, Xiao X, Bett C, Eraña H, Soldau K, Castilla J, Nilsson KP, Surewicz WK, Sigurdson CJ. Post-translational modifications in PrP expand the conformational diversity of prions in vivo. Scientific Reports. 7: 43295. PMID 28272426 DOI: 10.1038/Srep43295  0.483
2017 Theint T, Nadaud P, Surewicz K, Surewicz W, Jaroniec C. 13C and 15N Chemical Shift Assignments for Syrian Hamster Y145Stop Prion Protein Amyloid Fibrils Journal of Back and Musculoskeletal Rehabilitation. DOI: 10.13018/Bmr26926  0.406
2016 Theint T, Nadaud PS, Surewicz K, Surewicz WK, Jaroniec CP. (13)C and (15)N chemical shift assignments of mammalian Y145Stop prion protein amyloid fibrils. Biomolecular Nmr Assignments. PMID 28004358 DOI: 10.1007/S12104-016-9723-6  0.446
2016 Choi JK, Cali I, Surewicz K, Kong Q, Gambetti P, Surewicz WK. Amyloid fibrils from the N-terminal prion protein fragment are infectious. Proceedings of the National Academy of Sciences of the United States of America. PMID 27849581 DOI: 10.1073/Pnas.1610716113  0.483
2016 Scott-McKean JJ, Surewicz K, Choi JK, Ruffin VA, Salameh AI, Nieznanski K, Costa AC, Surewicz WK. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease. Neurobiology of Disease. PMID 26949218 DOI: 10.1016/J.Nbd.2016.03.001  0.392
2015 Williams TL, Choi JK, Surewicz K, Surewicz WK. Soluble Prion Protein Binds Isolated Low Molecular Weight Amyloid-β Oligomers Causing Cyto-toxicity Inhibition. Acs Chemical Neuroscience. PMID 26466138 DOI: 10.1021/Acschemneuro.5B00229  0.427
2015 Safar JG, Xiao X, Kabir ME, Chen S, Kim C, Haldiman T, Cohen Y, Chen W, Cohen ML, Surewicz WK. Structural determinants of phenotypic diversity and replication rate of human prions. Plos Pathogens. 11: e1004832. PMID 25875953 DOI: 10.1371/Journal.Ppat.1004832  0.459
2015 Cohen ML, Kim C, Haldiman T, ElHag M, Mehndiratta P, Pichet T, Lissemore F, Shea M, Cohen Y, Chen W, Blevins J, Appleby BS, Surewicz K, Surewicz WK, Sajatovic M, et al. Rapidly progressive Alzheimer's disease features distinct structures of amyloid-β. Brain : a Journal of Neurology. 138: 1009-22. PMID 25688081 DOI: 10.1093/Brain/Awv006  0.364
2014 Nieznanski K, Surewicz K, Chen S, Nieznanska H, Surewicz WK. Interaction between prion protein and Aβ amyloid fibrils revisited. Acs Chemical Neuroscience. 5: 340-5. PMID 24669873 DOI: 10.1021/Cn500019C  0.418
2014 Cobb NJ, Apostol MI, Chen S, Smirnovas V, Surewicz WK. Conformational stability of mammalian prion protein amyloid fibrils is dictated by a packing polymorphism within the core region. The Journal of Biological Chemistry. 289: 2643-50. PMID 24338015 DOI: 10.1074/Jbc.M113.520718  0.443
2013 Yuan J, Zhan YA, Abskharon R, Xiao X, Martinez MC, Zhou X, Kneale G, Mikol J, Lehmann S, Surewicz WK, Castilla J, Steyaert J, Zhang S, Kong Q, Petersen RB, et al. Recombinant human prion protein inhibits prion propagation in vitro. Scientific Reports. 3: 2911. PMID 24105336 DOI: 10.1038/Srep02911  0.431
2013 Dutta A, Chen S, Surewicz WK. The effect of β2-α2 loop mutation on amyloidogenic properties of the prion protein. Febs Letters. 587: 2918-23. PMID 23892077 DOI: 10.1016/J.Febslet.2013.07.023  0.421
2013 Kong Q, Mills JL, Kundu B, Li X, Qing L, Surewicz K, Cali I, Huang S, Zheng M, Swietnicki W, Sönnichsen FD, Gambetti P, Surewicz WK. Thermodynamic stabilization of the folded domain of prion protein inhibits prion infection in vivo. Cell Reports. 4: 248-54. PMID 23871665 DOI: 10.1016/J.Celrep.2013.06.030  0.476
2013 Apostol MI, Perry K, Surewicz WK. Crystal structure of a human prion protein fragment reveals a motif for oligomer formation. Journal of the American Chemical Society. 135: 10202-5. PMID 23808589 DOI: 10.1021/Ja403001Q  0.452
2013 Mills JL, Surewicz K, Surewicz W, Soennichsen FD. Solution Nmr Structure Of The V209M Variant Of The Human Prion Protein (Residues 90-231) Journal of Back and Musculoskeletal Rehabilitation. DOI: 10.2210/Pdb2M8T/Pdb  0.401
2012 Nieznanski K, Choi JK, Chen S, Surewicz K, Surewicz WK. Soluble prion protein inhibits amyloid-β (Aβ) fibrillization and toxicity. The Journal of Biological Chemistry. 287: 33104-8. PMID 22915585 DOI: 10.1074/Jbc.C112.400614  0.434
2012 Kim C, Haldiman T, Surewicz K, Cohen Y, Chen W, Blevins J, Sy MS, Cohen M, Kong Q, Telling GC, Surewicz WK, Safar JG. Small protease sensitive oligomers of PrPSc in distinct human prions determine conversion rate of PrP(C). Plos Pathogens. 8: e1002835. PMID 22876179 DOI: 10.1371/Journal.Ppat.1002835  0.434
2012 Liang J, Wang W, Sorensen D, Medina S, Ilchenko S, Kiselar J, Surewicz WK, Booth SA, Kong Q. Cellular prion protein regulates its own α-cleavage through ADAM8 in skeletal muscle. The Journal of Biological Chemistry. 287: 16510-20. PMID 22447932 DOI: 10.1074/Jbc.M112.360891  0.346
2011 Jones EM, Wu B, Surewicz K, Nadaud PS, Helmus JJ, Chen S, Jaroniec CP, Surewicz WK. Structural polymorphism in amyloids: new insights from studies with Y145Stop prion protein fibrils. The Journal of Biological Chemistry. 286: 42777-84. PMID 22002245 DOI: 10.1074/Jbc.M111.302539  0.48
2011 Helmus JJ, Surewicz K, Apostol MI, Surewicz WK, Jaroniec CP. Intermolecular alignment in Y145Stop human prion protein amyloid fibrils probed by solid-state NMR spectroscopy. Journal of the American Chemical Society. 133: 13934-7. PMID 21827207 DOI: 10.1021/Ja206469Q  0.43
2011 Surewicz WK, Apostol MI. Prion protein and its conformational conversion: a structural perspective. Topics in Current Chemistry. 305: 135-67. PMID 21630136 DOI: 10.1007/128_2011_165  0.486
2011 Apostol MI, Surewicz WK. Structural underpinnings of prion protein conversion. The Journal of Biological Chemistry. 286: le7; author reply Ie. PMID 21602283 DOI: 10.1074/Jbc.L110.213926  0.446
2011 Smirnovas V, Baron GS, Offerdahl DK, Raymond GJ, Caughey B, Surewicz WK. Structural organization of brain-derived mammalian prions examined by hydrogen-deuterium exchange. Nature Structural & Molecular Biology. 18: 504-6. PMID 21441913 DOI: 10.1038/Nsmb.2035  0.428
2011 Gambetti P, Cali I, Notari S, Kong Q, Zou WQ, Surewicz WK. Molecular biology and pathology of prion strains in sporadic human prion diseases. Acta Neuropathologica. 121: 79-90. PMID 21058033 DOI: 10.1007/S00401-010-0761-3  0.386
2010 Chen S, Yadav SP, Surewicz WK. Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues. The Journal of Biological Chemistry. 285: 26377-83. PMID 20576610 DOI: 10.1074/Jbc.M110.145516  0.426
2010 Kim JI, Cali I, Surewicz K, Kong Q, Raymond GJ, Atarashi R, Race B, Qing L, Gambetti P, Caughey B, Surewicz WK. Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. The Journal of Biological Chemistry. 285: 14083-7. PMID 20304915 DOI: 10.1074/Jbc.C110.113464  0.477
2010 Zou WQ, Langeveld J, Xiao X, Chen S, McGeer PL, Yuan J, Payne MC, Kang HE, McGeehan J, Sy MS, Greenspan NS, Kaplan D, Wang GX, Parchi P, Hoover E, ... ... Surewicz WK, et al. PrP conformational transitions alter species preference of a PrP-specific antibody. The Journal of Biological Chemistry. 285: 13874-84. PMID 20194495 DOI: 10.1074/Jbc.M109.088831  0.346
2010 Helmus JJ, Surewicz K, Surewicz WK, Jaroniec CP. Conformational flexibility of Y145Stop human prion protein amyloid fibrils probed by solid-state nuclear magnetic resonance spectroscopy. Journal of the American Chemical Society. 132: 2393-403. PMID 20121096 DOI: 10.1021/Ja909827V  0.432
2010 Lee S, Antony L, Hartmann R, Knaus KJ, Surewicz K, Surewicz WK, Yee VC. Conformational diversity in prion protein variants influences intermolecular beta-sheet formation. The Embo Journal. 29: 251-62. PMID 19927125 DOI: 10.1038/Emboj.2009.333  0.448
2009 Kim JI, Surewicz K, Gambetti P, Surewicz WK. The role of glycophosphatidylinositol anchor in the amplification of the scrapie isoform of prion protein in vitro. Febs Letters. 583: 3671-5. PMID 19854187 DOI: 10.1016/J.Febslet.2009.10.049  0.442
2009 Pasupuleti M, Roupe M, Rydengård V, Surewicz K, Surewicz WK, Chalupka A, Malmsten M, Sörensen OE, Schmidtchen A. Antimicrobial activity of human prion protein is mediated by its N-terminal region. Plos One. 4: e7358. PMID 19809501 DOI: 10.1371/Journal.Pone.0007358  0.42
2009 Smirnovas V, Kim JI, Lu X, Atarashi R, Caughey B, Surewicz WK. Distinct structures of scrapie prion protein (PrPSc)-seeded versus spontaneous recombinant prion protein fibrils revealed by hydrogen/deuterium exchange. The Journal of Biological Chemistry. 284: 24233-41. PMID 19596861 DOI: 10.1074/Jbc.M109.036558  0.472
2009 Cobb NJ, Surewicz WK. Prion diseases and their biochemical mechanisms. Biochemistry. 48: 2574-85. PMID 19239250 DOI: 10.1021/Bi900108V  0.425
2008 Cobb NJ, Apetri AC, Surewicz WK. Prion protein amyloid formation under native-like conditions involves refolding of the C-terminal alpha-helical domain. The Journal of Biological Chemistry. 283: 34704-11. PMID 18930924 DOI: 10.1074/Jbc.M806701200  0.475
2008 Ganchev DN, Cobb NJ, Surewicz K, Surewicz WK. Nanomechanical properties of human prion protein amyloid as probed by force spectroscopy. Biophysical Journal. 95: 2909-15. PMID 18539633 DOI: 10.1529/Biophysj.108.133108  0.417
2008 Helmus JJ, Surewicz K, Nadaud PS, Surewicz WK, Jaroniec CP. Molecular conformation and dynamics of the Y145Stop variant of human prion protein in amyloid fibrils. Proceedings of the National Academy of Sciences of the United States of America. 105: 6284-9. PMID 18436646 DOI: 10.1073/Pnas.0711716105  0.471
2008 Yuan J, Dong Z, Guo JP, McGeehan J, Xiao X, Wang J, Cali I, McGeer PL, Cashman NR, Bessen R, Surewicz WK, Kneale G, Petersen RB, Gambetti P, Zou WQ. Accessibility of a critical prion protein region involved in strain recognition and its implications for the early detection of prions. Cellular and Molecular Life Sciences : Cmls. 65: 631-43. PMID 18193391 DOI: 10.1007/S00018-007-7478-Z  0.364
2007 Cobb NJ, Sönnichsen FD, McHaourab H, Surewicz WK. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure. Proceedings of the National Academy of Sciences of the United States of America. 104: 18946-51. PMID 18025469 DOI: 10.1073/Pnas.0706522104  0.475
2007 Cobb NJ, Surewicz WK. Prion strains under the magnifying glass. Nature Structural & Molecular Biology. 14: 882-4. PMID 17912257 DOI: 10.1038/Nsmb1007-882  0.381
2007 Surewicz WK. Protein science: discriminating taste of prions. Nature. 447: 541-2. PMID 17538609 DOI: 10.1038/447541B  0.388
2007 Lu X, Wintrode PL, Surewicz WK. Beta-sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange. Proceedings of the National Academy of Sciences of the United States of America. 104: 1510-5. PMID 17242357 DOI: 10.1073/Pnas.0608447104  0.459
2007 Davoodi J, Wakarchuk WW, Carey PR, Surewicz WK. Mechanism of stabilization of Bacillus circulans xylanase upon the introduction of disulfide bonds. Biophysical Chemistry. 125: 453-61. PMID 17141401 DOI: 10.1016/J.Bpc.2006.10.006  0.31
2006 Surewicz WK, Jones EM, Apetri AC. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro. Accounts of Chemical Research. 39: 654-62. PMID 16981682 DOI: 10.1021/Ar050226C  0.468
2006 Apetri AC, Maki K, Roder H, Surewicz WK. Early intermediate in human prion protein folding as evidenced by ultrarapid mixing experiments. Journal of the American Chemical Society. 128: 11673-8. PMID 16939293 DOI: 10.1021/Ja063880B  0.443
2006 Jones EM, Surewicz K, Surewicz WK. Role of N-terminal familial mutations in prion protein fibrillization and prion amyloid propagation in vitro. The Journal of Biological Chemistry. 281: 8190-6. PMID 16443601 DOI: 10.1074/Jbc.M513417200  0.479
2005 Apetri AC, Vanik DL, Surewicz WK. Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231. Biochemistry. 44: 15880-8. PMID 16313190 DOI: 10.1021/Bi051455+  0.445
2005 Jones EM, Surewicz WK. Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids. Cell. 121: 63-72. PMID 15820679 DOI: 10.1016/J.Cell.2005.01.034  0.447
2004 Vanik DL, Surewicz KA, Surewicz WK. Molecular basis of barriers for interspecies transmissibility of mammalian prions. Molecular Cell. 14: 139-45. PMID 15068810 DOI: 10.1016/S1097-2765(04)00155-8  0.408
2004 Apetri AC, Surewicz K, Surewicz WK. The effect of disease-associated mutations on the folding pathway of human prion protein. The Journal of Biological Chemistry. 279: 18008-14. PMID 14761942 DOI: 10.1074/Jbc.M313581200  0.468
2003 Kundu B, Maiti NR, Jones EM, Surewicz KA, Vanik DL, Surewicz WK. Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation. Proceedings of the National Academy of Sciences of the United States of America. 100: 12069-74. PMID 14519851 DOI: 10.1073/Pnas.2033281100  0.488
2003 Apetri AC, Surewicz WK. Atypical effect of salts on the thermodynamic stability of human prion protein. The Journal of Biological Chemistry. 278: 22187-92. PMID 12676939 DOI: 10.1074/Jbc.M302130200  0.444
2002 Vanik DL, Surewicz WK. Disease-associated F198S mutation increases the propensity of the recombinant prion protein for conformational conversion to scrapie-like form. The Journal of Biological Chemistry. 277: 49065-70. PMID 12372829 DOI: 10.1074/Jbc.M207511200  0.495
2002 Apetri AC, Surewicz WK. Kinetic intermediate in the folding of human prion protein. The Journal of Biological Chemistry. 277: 44589-92. PMID 12356762 DOI: 10.1074/Jbc.C200507200  0.466
2002 Moscardini M, Pistello M, Bendinelli M, Ficheux D, Miller JT, Gabus C, Le Grice SF, Surewicz WK, Darlix JL. Functional interactions of nucleocapsid protein of feline immunodeficiency virus and cellular prion protein with the viral RNA. Journal of Molecular Biology. 318: 149-59. PMID 12054775 DOI: 10.1016/S0022-2836(02)00092-X  0.353
2001 Knaus KJ, Morillas M, Swietnicki W, Malone M, Surewicz WK, Yee VC. Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nature Structural Biology. 8: 770-4. PMID 11524679 DOI: 10.1038/Nsb0901-770  0.462
2001 Morillas M, Vanik DL, Surewicz WK. On the Mechanism of α-Helix to β-Sheet Transition in the Recombinant Prion Protein† Biochemistry. 40: 6982-6987. PMID 11389614 DOI: 10.1021/Bi010232Q  0.413
2001 Gabus C, Auxilien S, Péchoux C, Dormont D, Swietnicki W, Morillas M, Surewicz W, Nandi P, Darlix JL. The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein. Journal of Molecular Biology. 307: 1011-21. PMID 11286552 DOI: 10.1006/Jmbi.2001.4544  0.389
2001 Gabus C, Derrington E, Leblanc P, Chnaiderman J, Dormont D, Swietnicki W, Morillas M, Surewicz WK, Marc D, Nandi P, Darlix JL. The prion protein has RNA binding and chaperoning properties characteristic of nucleocapsid protein NCP7 of HIV-1. The Journal of Biological Chemistry. 276: 19301-9. PMID 11278562 DOI: 10.1074/Jbc.M009754200  0.347
2001 Maiti NR, Surewicz WK. The role of disulfide bridge in the folding and stability of the recombinant human prion protein. Journal of Biological Chemistry. 276: 2427-2431. PMID 11069909 DOI: 10.1074/Jbc.M007862200  0.494
2000 Li R, Liu T, Wong BS, Pan T, Morillas M, Swietnicki W, O'Rourke K, Gambetti P, Surewicz WK, Sy MS. Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus. Journal of Molecular Biology. 301: 567-73. PMID 10966770 DOI: 10.1006/Jmbi.2000.3986  0.373
2000 Zhang Y, Swietnicki W, Zagorski MG, Surewicz WK, Sönnichsen FD. Solution structure of the E200K variant of human prion protein. Implications for the mechanism of pathogenesis in familial prion diseases. The Journal of Biological Chemistry. 275: 33650-4. PMID 10954699 DOI: 10.1074/Jbc.C000483200  0.486
2000 Reddy GB, Das KP, Petrash JM, Surewicz WK. Temperature-dependent chaperone activity and structural properties of human alphaA- and alphaB-crystallins. The Journal of Biological Chemistry. 275: 4565-70. PMID 10671481 DOI: 10.1074/Jbc.275.7.4565  0.306
2000 Swietnicki W, Morillas M, Chen SG, Gambetti P, Surewicz WK. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231. Biochemistry. 39: 424-31. PMID 10631004 DOI: 10.1021/Bi991967M  0.492
2000 Zhang Y, Swietnicki W, Zagorski MG, Surewicz WK, Soennichsen FD. Human Prion Protein Mutant E200K Fragment 90-231 Journal of Back and Musculoskeletal Rehabilitation. DOI: 10.2210/Pdb1Fkc/Pdb  0.389
1999 Morillas M, Swietnicki W, Gambetti P, Surewicz WK. Membrane environment alters the conformational structure of the recombinant human prion protein. Journal of Biological Chemistry. 274: 36859-36865. PMID 10601237 DOI: 10.1074/Jbc.274.52.36859  0.437
1999 Das KP, Choo-Smith LP, Petrash JM, Surewicz WK. Insight into the secondary structure of non-native proteins bound to a molecular chaperone alpha-crystallin. An isotope-edited infrared spectroscopic study. The Journal of Biological Chemistry. 274: 33209-12. PMID 10559193 DOI: 10.1074/Jbc.274.47.33209  0.408
1998 Swietnicki W, Petersen RB, Gambetti P, Surewicz WK. Familial mutations and the thermodynamic stability of the recombinant human prion protein. The Journal of Biological Chemistry. 273: 31048-52. PMID 9813003 DOI: 10.1074/Jbc.273.47.31048  0.393
1998 Davoodi J, Wakarchuk WW, Surewicz WK, Carey PR. Scan-rate dependence in protein calorimetry: The reversible transitions of Bacillus circulans xylanase and a disulfide-bridge mutant Protein Science. 7: 1538-1544. PMID 9684886 DOI: 10.1002/Pro.5560070707  0.352
1998 Perrier V, Burlacu-Miron S, Bourgeois S, Surewicz WK, Gilles AM. Genetically engineered zinc-chelating adenylate kinase from Escherichia coli with enhanced thermal stability. Journal of Biological Chemistry. 273: 19097-19101. PMID 9668094 DOI: 10.1074/Jbc.273.30.19097  0.319
1997 Swietnicki W, Petersen R, Gambetti P, Surewicz WK. pH-dependent stability and conformation of the recombinant human prion protein PrP(90-231) Journal of Biological Chemistry. 272: 27517-27520. PMID 9346881 DOI: 10.1074/Jbc.272.44.27517  0.448
1997 Butko P, Huang F, Pusztai-Carey M, Surewicz WK. Interaction of the δ-endotoxin CytA from Bacillus thuringiensis var. israelensis with lipid membranes Biochemistry. 36: 12862-12868. PMID 9335544 DOI: 10.1021/Bi9702389  0.307
1997 Choo-Smith LP, Garzon-Rodriguez W, Glabe CG, Surewicz WK. Acceleration of amyloid fibril formation by specific binding of Abeta-(1-40) peptide to ganglioside-containing membrane vesicles. The Journal of Biological Chemistry. 272: 22987-90. PMID 9287293 DOI: 10.1074/Jbc.272.37.22987  0.337
1997 Sayre LM, Zagorski MG, Surewicz WK, Krafft GA, Perry G. Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: a critical appraisal. Chemical Research in Toxicology. 10: 518-26. PMID 9168248 DOI: 10.1021/Tx970009N  0.316
1997 Choo-Smith LPI, Surewicz WK. The interaction between Alzheimer amyloid β(1–40) peptide and ganglioside GM1‐containing membranes Febs Letters. 402: 95-98. PMID 9037173 DOI: 10.1016/S0014-5793(96)01504-9  0.388
1996 Serina L, Bucurenci N, Gilles AM, Surewicz WK, Fabian H, Mantsch HH, Takahashi M, Petrescu I, Batelier G, Bârzu O. Structural Properties of UMP-Kinase from Escherichia coli: Modulation of Protein Solubility by pH and UTP† Biochemistry. 35: 7003-7011. PMID 8679525 DOI: 10.1021/Bi960062V  0.36
1996 Das KP, Petrash JM, Surewicz WK. Conformational properties of substrate proteins bound to a molecular chaperone alpha-crystallin. The Journal of Biological Chemistry. 271: 10449-52. PMID 8631839 DOI: 10.1074/Jbc.271.18.10449  0.377
1995 Das KP, Surewicz WK. Temperature-induced exposure of hydrophobic surfaces and its effect on the chaperone activity of alpha-crystallin. Febs Letters. 369: 321-5. PMID 7649280 DOI: 10.1016/0014-5793(95)00775-5  0.361
1995 Surewicz WK, Olesen PR. On the thermal stability of alpha-crystallin: a new insight from infrared spectroscopy Biochemistry. 34: 9655-9660. PMID 7626634 DOI: 10.1021/Bi00030A001  0.384
1995 Das KP, Surewicz WK. On the substrate specificity of alpha-crystallin as a molecular chaperone. The Biochemical Journal. 311: 367-70. PMID 7487869 DOI: 10.1042/Bj3110367  0.361
1995 Davoodi J, Wakarchuk WW, Campbell RL, Carey PR, Surewicz WK. Abnormally High pK a of an Active-Site Glutamic Acid Residue in Bacillus Circulans Xylanase. The Role of Electrostatic Interactions European Journal of Biochemistry. 232: 839-843. DOI: 10.1111/J.1432-1033.1995.Tb20881.X  0.336
1995 Davoodi J, Wakarchuk WW, Campbell RL, Carey PR, Surewicz WK. Abnormally High pKa of an Active‐Site Glutamic Acid Residue in Bacillus Circulans Xylanase Febs Journal. 232: 839-843. DOI: 10.1111/J.1432-1033.1995.0839A.X  0.333
1994 Muga A, Neugebauer W, Hirama T, Surewicz WK. Membrane Interaction and Conformational Properties of the Putative Fusion Peptide of PH-30, a Protein Active in Sperm-Egg Fusion Biochemistry. 33: 4444-4448. PMID 8161498 DOI: 10.1021/Bi00181A002  0.373
1994 Perrier V, Surewicz WK, Glaser P, Martineau L, Craescu CT, Fabian H, Mantsch HH, Barzu O, Gilles A. Zinc chelation and structural stability of adenylate kinase from Bacillus subtilis Biochemistry. 33: 9960-9967. PMID 8061005 DOI: 10.1021/Bi00199A019  0.322
1994 Fraser PE, McLachlan DR, Surewicz WK, Mizzen CA, Snow AD, Nguyen JT, Kirschner DA. Conformation and fibrillogenesis of Alzheimer A beta peptides with selected substitution of charged residues. Journal of Molecular Biology. 244: 64-73. PMID 7966323 DOI: 10.1006/Jmbi.1994.1704  0.38
1993 Surewicz WK, Mantsch HH, Chapman D. Determination of protein secondary structure by Fourier transform infrared spectroscopy: A critical assessment Biochemistry. 32: 389-394. PMID 8422346 DOI: 10.1021/Bi00053A001  0.352
1993 Gilles A, Sismeiro O, Munier H, Fabian H, Mantsch HH, Surewicz WK, Craescu CC, Barzu O, Danchin A. Structural and physico-chemical characteristics of Bordetella pertussis adenylate kinase, a tryptophan-containing enzyme Febs Journal. 218: 921-927. PMID 8281944 DOI: 10.1111/J.1432-1033.1993.Tb18448.X  0.308
1993 Kallwass HK, Surewicz WK, Parris W, Macfarlane EL, Luyten MA, Kay CM, Gold M, Jones JB. Single amino acid substitutions can further increase the stability of a thermophilic L-lactate dehydrogenase. Protein Engineering. 5: 769-74. PMID 1287656 DOI: 10.1093/Protein/5.8.769  0.344
1992 Epand RM, Gabel B, Epand RF, Sen A, Hui SW, Muga A, Surewicz WK. Formation of a new stable phase of phosphatidylglycerols. Biophysical Journal. 63: 327-32. PMID 1420881 DOI: 10.1016/S0006-3495(92)81618-1  0.306
1992 Fraser PE, Nguyen JT, Inouye H, Surewicz WK, Selkoe DJ, Podlisny MB, Kirschner DA. Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid beta-protein. Biochemistry. 31: 10716-23. PMID 1420187 DOI: 10.1021/Bi00159A011  0.397
1992 Neugebauer W, Surewicz WK, Gordon HL, Somorjai RL, Sung W, Willick GE. Structural elements of human parathyroid hormone and their possible relation to biological activities. Biochemistry. 31: 2056-63. PMID 1311201 DOI: 10.1021/Bi00122A023  0.387
1991 Labruyere E, Mock M, Surewicz WK, Mantsch HH, Rose T, Munier H, Sarfati RS, Barzu O. Structural and ligand-binding properties of a truncated form of Bacillus anthracis adenylate cyclase and of a catalytically inactive variant in which glutamine substitutes for lysine-346. Biochemistry. 30: 2619-2624. PMID 1900429 DOI: 10.1021/Bi00224A008  0.4
1991 Choma CT, Surewicz WK, Kaplan H. The toxic moiety of the Bacillus thuringiensis protoxin undergoes a conformational change upon activation. Biochemical and Biophysical Research Communications. 179: 933-8. PMID 1898414 DOI: 10.1016/0006-291X(91)91908-U  0.37
1991 Muga A, Mantsch HH, Surewicz WK. Apocytochrome c interaction with phospholipid membranes studied by Fourier-transform infrared spectroscopy. Biochemistry. 30: 2629-2635. PMID 1848092 DOI: 10.1021/Bi00224A010  0.416
1991 Fraser PE, Nguyen JT, Surewicz WK, Kirschner DA. pH-dependent structural transitions of Alzheimer amyloid peptides. Biophysical Journal. 60: 1190-201. PMID 1760507 DOI: 10.1016/S0006-3495(91)82154-3  0.399
1991 Muga A, Mantsch HH, Surewicz WK. Membrane binding induces destabilization of cytochrome c structure. Biochemistry. 30: 7219-7224. PMID 1649625 DOI: 10.1021/Bi00243A025  0.389
1990 Choma CT, Surewicz WK, Carey PR, Pozsgay M, Kaplan H. Secondary structure of the entomocidal toxin from Bacillus thuringiensis subsp. kurstaki HD-73 Journal of Protein Chemistry. 9: 87-94. PMID 2340079 DOI: 10.1007/Bf01024989  0.329
1990 Muga A, Surewicz WK, Wong PTT, Mantsch HH. Structural studies with the uveopathogenic peptide M derived from retinal S-antigen. Biochemistry. 29: 2925-2930. PMID 2337574 DOI: 10.1021/Bi00464A006  0.362
1990 Surewicz WK, Leddy JJ, Mantsch HH. Structure, stability, and receptor interaction of cholera toxin as studied by Fourier-transform infrared spectroscopy. Biochemistry. 29: 8106-11. PMID 2261465 DOI: 10.1021/Bi00487A017  0.322
1990 Choma CT, Surewicz WK, Carey PR, Pozsgay M, Raynor T, Kaplan H. Unusual proteolysis of the protoxin and toxin from Bacillus thuringiensis. Structural implications European Journal of Biochemistry. 189: 523-527. PMID 2190826 DOI: 10.1111/J.1432-1033.1990.Tb15518.X  0.336
1990 Surewicz WK, Mantsch HH. The conformation of proteins and peptides in a membrane environment: an infrared spectroscopic approach. Biotechnology(Faisalabad). 14: 131-157. PMID 2183896 DOI: 10.1016/B978-0-409-90116-0.50015-7  0.368
1990 Whitaker JN, Moscarello MA, Herman PK, Epand RM, Surewicz WK. Conformational correlates of the epitopes of human myelin basic protein peptide 80-89. Journal of Neurochemistry. 55: 568-76. PMID 1695239 DOI: 10.1111/J.1471-4159.1990.Tb04171.X  0.365
1989 Surewicz WK, Surewicz K, Mantsch HH, Auclair F. Interaction of Shigella toxin with globotriaosyl ceramide receptor-containing membranes: a fluorescence study. Biochemical and Biophysical Research Communications. 160: 126-132. PMID 2653314 DOI: 10.1016/0006-291X(89)91630-6  0.302
1988 Surewicz WK, Mantsch HH. Solution and membrane structure of enkephalins as studied by infrared spectroscopy Biochemical and Biophysical Research Communications. 150: 245-251. PMID 3337714 DOI: 10.1016/0006-291X(88)90512-8  0.351
1988 Surewicz WK, Mantsch HH. New insight into protein secondary structure from resolution-enhanced infrared spectra. Biochimica Et Biophysica Acta. 952: 115-130. PMID 3276352 DOI: 10.1016/0167-4838(88)90107-0  0.372
1988 Epand RM, Surewicz WK, Yeagle P. Role of peptide structure in lipid-peptide interactions: nuclear magnetic resonance study of the interaction of pentagastrin and [Arg4]pentagastrin with dimyristoylphosphatidylcholine. Chemistry and Physics of Lipids. 49: 105-10. PMID 3233705 DOI: 10.1016/0009-3084(88)90071-0  0.322
1987 Surewicz WK, Epand RM, Orlowski RC, Mantsch HH. Structural properties of acidic phospholipids in complexes with calcitonin: a Fourier transform infrared spectroscopic investigation. Biochimica Et Biophysica Acta. 899: 307-310. PMID 3580371 DOI: 10.1016/0005-2736(87)90413-5  0.326
1987 Surewicz WK, Szabo AG, Mantsch HH. Conformational properties of azurin in solution as determined from resolution-enhanced Fourier-transform infrared spectra European Journal of Biochemistry. 167: 519-523. PMID 3115776 DOI: 10.1111/J.1432-1033.1987.Tb13368.X  0.395
1987 Surewicz WK, Mantsch HH, Stahl GL, Epand RM. Infrared spectroscopic evidence of conformational transitions of an atrial natriuretic peptide. Proceedings of the National Academy of Sciences of the United States of America. 84: 7028-7030. PMID 2959955 DOI: 10.1073/Pnas.84.20.7028  0.386
1987 Surewicz WK, Moscarello MA, Mantsch HH. Fourier transform infrared spectroscopic investigation of the interaction between myelin basic protein and dimyristoylphosphatidylglycerol bilayers. Biochemistry. 26: 3881-6. PMID 2443163 DOI: 10.1021/Bi00387A021  0.441
1986 Surewicz WK, Epand RM. Phospholipid structure determines the effects of peptides on membranes. Differential scanning calorimetry studies with pentagastrin-related peptides. Biochimica Et Biophysica Acta. 856: 290-300. PMID 3955044 DOI: 10.1016/0005-2736(86)90039-8  0.328
1986 Surewicz WK, Epand RM, Epand RF, Hallett FR, Moscarello MA. Modulation of myelin basic protein-induced aggregation and fusion of liposomes by cholesterol, aliphatic aldehydes and alkanes. Biochimica Et Biophysica Acta. 863: 45-52. PMID 2430621 DOI: 10.1016/0005-2736(86)90385-8  0.356
1985 Surewicz WK, Epand RM. Role of peptide structure in lipid-peptide interactions: high-sensitivity differential scanning calorimetry and electron spin resonance studies of the structural properties of dimyristoylphosphatidylcholine membranes interacting with pentagastrin-related pentapeptides. Biochemistry. 24: 3135-3144. PMID 2992577 DOI: 10.1021/Bi00334A010  0.328
1985 Surewicz WK, Epand RM, Vail WJ, Moscarello MA. Aliphatic aldehydes promote myelin basic protein-induced fusion of phospholipid vesicles. Biochimica Et Biophysica Acta. 820: 319-23. PMID 2413893 DOI: 10.1016/0005-2736(85)90127-0  0.334
1984 Surewicz WK, Epand RM. Role of peptide structure in lipid-peptide interactions: a fluorescence study of the binding of pentagastrin-related pentapeptides to phospholipid vesicles. Biochemistry. 23: 6072-6077. PMID 6525344 DOI: 10.1021/Bi00320A026  0.358
1984 Epand RM, Dell K, Surewicz WK, Moscarello MA. Effect of lipid structure on the capacity of myelin basic protein to alter vesicle properties: potent effects of aliphatic aldehydes in promoting basic protein-induced vesicle aggregation. Journal of Neurochemistry. 43: 1550-5. PMID 6208335 DOI: 10.1111/J.1471-4159.1984.Tb06077.X  0.392
Show low-probability matches.